Multiple defects in macrophage antibacterial responses support intracellular survival of Mycobacterium abscessus in cystic fibrosis
Proceedings of the National Academy of Sciences · 02.06.2026 · 123 (22)
DOI: 10.1073/pnas.2537320123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 27.05.2026. Verfasst von Abdullah A Tarique und 16 weiteren Autor:innen. Beteiligte Einrichtung: Children's Health and Environment Program, Child Health Research Centre, The University of Queensland, Brisbane, QLD 4101, Australia. Hauptthemen laut MEDLINE: Cystic Fibrosis, Macrophages, Mycobacterium abscessus, Mycobacterium Infections, Nontuberculous. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cystic Fibrosis Foundation (CFF), Vertex Pharmaceuticals, DHAC | National Health and Medical Research Council (NHMRC).
Abstract (Originalsprache)
The prevalence of Mycobacterium abscessus (MABS) infections in people with cystic fibrosis (pwCF) is increasing. Macrophages are key phagocytic cells that recognize bacteria via cell surface receptors, engulf them into phagosomes, and then utilize diverse killing strategies. Here, we used human primary monocyte-derived macrophages (MDMs) from healthy controls (HCs) and pwCF to investigate how they processed and killed MABS. Expression of phagocytosis-related pattern recognition receptors (TLR2, Dectin-1, Dectin-2, and MARCO), engulfment of MABS, and lysosomal acidity were all reduced in CF-MDMs. MABS-infected CF-MDMs also had reduced mitochondrial mass, mitochondrial reactive oxygen species (mitoROS) production, relative intracellular zinc levels and inducible mRNA expression of the antibacterial zinc transporters, SLC30A1 and SLC39A8. Stimulation of mitoROS production in HC-MDMs with antimycin A reduced intracellular loads of MABS, confirming that MABS are sensitive to this mechanism of killing and suggesting that the mitoROS defect in MABS-infected CF-MDMs compromises bacterial killing. Accordingly, CF-MDMs failed to control MABS infection, with these cells allowing significantly increased intracellular MABS survival and expansion over 6 d. While treatment with the CFTR modulator, elexacaftor–tezacaftor–ivacaftor (ETI) did increase CFTR channel function and corrected CF macrophage functions to some degree, this was not sufficient to increase MABS killing. Taken together, our findings suggest important roles for functional CFTR in internalization and killing of MABS within macrophages, with CFTR dysfunction supporting MABS survival and replication in macrophages. Under our experimental conditions, ETI treatment failed to fully restore macrophage functions against MABS, highlighting the need for alternative, host-targeted approaches for improving macrophage functions in CF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Children's Health and Environment Program, Child Health Research Centre, The University of Queensland, Brisbane, QLD 4101, Australia.
- Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, QLD 4072, Australia.
- Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia.
- Respiratory and Sleep Medicine, Queensland Children's Hospital, Brisbane, QLD 4101, Australia.
- Institut national de recherche pour l'agriculture, l'alimentation et l'environnement, Université de Tours, Infectiologie et Santé Publique, Nouzilly 37380, France.
- Centre National de la Recherche Scientifique, UMR 9004, Institut de Recherche en Infectiologie de Montpellier, Université de Montpellier, Montpellier 34293, France.
ORCID-Profile: Abdullah A Tarique, Stefan Emming, Dean Kelk, Jayden Logan, Divya Ramanth, Emma K Dalton, Kaustav Das Gupta, Tamara Blake, James E B Curson, Syeda Farhana Afroz, Matthew J Sweet, Claire E Wainwright, Ronan Kapetanovic, Laurent Kremer, Scott C Bell, Emmanuelle Fantino, Peter D Sly
Förderung
- Cystic Fibrosis Foundation (CFF)
- Vertex Pharmaceuticals
- DHAC | National Health and Medical Research Council (NHMRC)
Zitieren
APA
Tarique, A. A., Emming, S., Kelk, D., Logan, J., Ramanth, D., Dalton, E. K., Das Gupta, K., Blake, T., Curson, J. E. B., Afroz, S. F., Sweet, M. J., Wainwright, C. E., Kapetanovic, R., Kremer, L., Bell, S. C., Fantino, E., & Sly, P. D. (2026). Multiple defects in macrophage antibacterial responses support intracellular survival of Mycobacterium abscessus in cystic fibrosis. Proceedings of the National Academy of Sciences, 123(22). https://doi.org/10.1073/pnas.2537320123
Vancouver
Tarique AA, Emming S, Kelk D, Logan J, Ramanth D, Dalton EK, et al. Multiple defects in macrophage antibacterial responses support intracellular survival of Mycobacterium abscessus in cystic fibrosis. Proceedings of the National Academy of Sciences. 2026;123(22). doi:10.1073/pnas.2537320123
BibTeX
@article{Tarique2026,
author = {Tarique, Abdullah A and Emming, Stefan and Kelk, Dean and Logan, Jayden and Ramanth, Divya and Dalton, Emma K and Das Gupta, Kaustav and Blake, Tamara and Curson, James E B and Afroz, Syeda Farhana and Sweet, Matthew J and Wainwright, Claire E and Kapetanovic, Ronan and Kremer, Laurent and Bell, Scott C and Fantino, Emmanuelle and Sly, Peter D},
title = {Multiple defects in macrophage antibacterial responses support intracellular survival of Mycobacterium abscessus in cystic fibrosis},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {22},
doi = {10.1073/pnas.2537320123}
}
EUVIMED